Daniel Irimia MD, PhD

Daniel Irimia, MD, PhD, is an Associate Professor and Deputy Director of the BioMEMS Resource Center at the Center for Engineering in Medicine (CEM). He is an internationally recognized expert in bioengineered microsystems for cellular chemotaxis and other functional assays. Dr. Irimia’s scholarship is reflected in more than 100 publications, of which more than 60 in the past 5 years. He is senior author on publications in leading journals, including Nature Biomedical Engineering, Nature Materials, Nature Communications, and PNAS.

He is co-author on publications that employ novel microfluidic devices towards biology discoveries, published in journals like Science, Nature Medicine, Science Translational Medicine, Cell Host and Microbe. These publications have been cited more than 5,000 times. Dr. Irimia is the organizer of the Cell World Races, aimed at encouraging scientists and clinician-researchers to utilize microfluidic tools in their research for higher level of precision and detail that are not currently possible using any of the other tools.

This unorthodox approach increases the awareness for the technological changes taking place in the field of cell motility and has been recently featured on the front page of Wall Street Journal (March 2014) , and covered in news articles in Nature. In 2012, Dr. Irimia was one of the winners of the Wellcome Image Awards for the depiction of “Cancer cells in motion.” In 2016, he was awarded the "Pioneers of Miniaturization" prize from the Chemical and Biological Microsystems Society for his work on microfluidic devices for studying neutrophils and other leukocytes.